LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

Search

Penumbra Inc

Fechado

SetorSaúde

338.48 -0.53

Visão Geral

Variação de preço das ações

24h

Atual

Mín

337.48

Máximo

340.45

Indicadores-chave

By Trading Economics

Rendimento

-176M

-130M

Vendas

31M

385M

P/E

Médio do Setor

81.89

66.845

Margem de lucro

-33.822

Funcionários

4,700

EBITDA

13M

68M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+9.64% upside

Dividendos

By Dow Jones

Próximos Ganhos

22 de abr. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

122M

13B

Abertura anterior

339.01

Fecho anterior

338.48

Sentimento de Notícias

By Acuity

67%

33%

306 / 351 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bearish Evidence

Penumbra Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

15 de jan. de 2026, 13:29 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- 2nd Update

15 de jan. de 2026, 12:35 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- Update

15 de jan. de 2026, 12:29 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

25 de fev. de 2026, 18:02 UTC

Ganhos

Penumbra: Won't Be Providing Financial Guidance for 2026, Citing Proposed Boston Scientific Deal

25 de fev. de 2026, 18:01 UTC

Ganhos

Penumbra 4Q Rev $385.4M >PEN

25 de fev. de 2026, 18:01 UTC

Ganhos

Penumbra 4Q Adj EPS $1.18 >PEN

25 de fev. de 2026, 18:01 UTC

Ganhos

Penumbra 4Q EPS $1.20 >PEN

24 de jan. de 2026, 06:18 UTC

Aquisições, Fusões, Aquisições de Empresas

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

15 de jan. de 2026, 14:37 UTC

Ações em Alta

Stocks to Watch Thursday: Goldman Sachs, Boston Scientific, BlackRock -- WSJ

15 de jan. de 2026, 13:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion. -- Barrons.com

15 de jan. de 2026, 12:04 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific: Penumbra Shareholders Can Elect to Receive Cash or Stock >BSX PEN

15 de jan. de 2026, 12:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific: Acquisition to Expand Cardiovascular Portfolio >BSX PEN

15 de jan. de 2026, 12:01 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific: Penumbra Deal Carriers an Enterprise Value of About $14.5 Billion >BSX

15 de jan. de 2026, 12:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific to Buy Penumbra for $374/Share >BSX PEN

15 de jan. de 2026, 12:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific Announces Agreement To Acquire Penumbra, Inc. >BSX PEN

Comparação entre Pares

Variação de preço

Penumbra Inc Previsão

Preço-alvo

By TipRanks

9.64% parte superior

Previsão para 12 meses

Média 372.36 USD  9.64%

Máximo 374 USD

Mínimo 360 USD

Com base em 15 analistas de Wall Street que oferecem metas de preço de 12 meses para Penumbra Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

15 ratings

3

Comprar

12

Manter

0

Vender

Pontuação Técnica

By Trading Central

288.28 / 292.9394Suporte e Resistência

Curto Prazo

Bearish Evidence

Médio Prazo

Bullish Evidence

Longo Prazo

Weak Bullish Evidence

Sentimento

By Acuity

306 / 351 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat